glp-1 for diabetic Activator List of approved and pending
Description
So yes, there are a lot of different kind of knock-on effects here
A growing body of research shows GLP-1 receptor agonists lower the risk of major cardiovascular events, including heart attacks and strokes, particularly in people with Type 2 diabetes
[Google Scholar] 13.EMA
[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Montero A, Sparks G, Presiado M, Hamel L
